Onsite basic health screening and brief health counseling of chronic medical conditions for veterans in methadone maintenance treatment

Journal of Addiction Medicine

Volumn 4, Issue 3, 2010, Pages 160-166

  Fareed, Ayman ^a,b   Musselman, Dominique ^a,b   Byrd Sellers, Johnita ^a   Vayalapalli, Sreedevi ^a,b   Casarella, Jennifer ^a,b   Drexler, Karen ^a,b   Phillips, Lawrence S ^a,b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Health education; Health promotion; Mass screening; Methadone

Indexed keywords

EID: 78249288022     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3181b6f4e5     Document Type: Article

References (34)

1. Alterman AL, Rutherford MJ, Cacciola JS, et al. Prediction of 7 months methadone maintenance treatment response by four measures of anti- sociality. Drug Alcohol Depend 1998;49:217-223.
2. Arao M, Murase K, Kusakabe A, et al. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003;38:355-360.
3. Aytug S, Reich D, Sapiro LE, et al. Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes. Hepatology 2003;38:1384-1392.
4. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcome. New York: Springer-Verlag; 1991.
5. Bernsmeier C, Duong FH, Christen V, et al. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C. J Hepatol 2008;49:429-440.
6. Broers B, Morabia A, Hirschel B. A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med 1994;154:1121-1127.
7. Brugal MT, Domingo-Salvany A, Puig R, et al. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005;100:981-989.
8. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology 2005;42:987-1000.
9. Centers for Disease Control and Prevention (CDC). Prevalence of current cigarette smoking among adults and changes in prevalence of current and some day smoking. United States. 1996-2001. MMWR Morb Mortal Wkly 2003;52:303-307.
10. Centers for Disease Control and Prevention (CDC). Prevalence of self-reported physically active adults - United States, 2007. MMWR Morb Mortal Wkly Rep 2008;57:1297-300.
11. Ceriello A, Giugliano D, Passariello N, et al. Impaired glucose metabolism in heroin and methadone users. Horm Metabol Res 1987;19:430-433.
12. Chao A, Thun MJ, Jacobs EJ, et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst 2000; 92:1888-1896.
13. Davila DG, Williams DE. The etiology of lung cancer. Mayo Clin Proc 1993;68:170-182.
14. Department of Health and Human Services, Public Health Service. Publication No. PHS 82-50179. Health consequences of smoking: A report of the Surgeon General. Washington, DC: US Government Printing Office; 1982.
15. Dole VP, Nyswander ME. A medical treatment for diacetyl morphine (heroin) addiction: A clinical trial with methadone hydrochloride. JAMA 1965;193:646-650.
16. Fareed A, Casarella J, Amar R, et al. "Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts." J Psych Pract 2009;15:227-234.
17. Howard AA, Floris-Moore M, Arnsten JH, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis 2005;40: 1492-1499.
18. Howard AA, Floris-Moore M, Lo Y, et al. Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med 2006;7: 389-396.
19. Howard AA, Klein RS, Schoenbaum EE. Association ofhepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis 2003;36:1318-1323.
20. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003;125:1695-1704.
21. Kawaguchi T, Yoshida T, Harada M, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004;165:1499-1508.
22. Krantz MJ, Martin J, Stimmel B, et al. QTc interval screening in methadone treatment. Ann Intern Med 2009;150:387-395.
23. Ling W, Charuvastra VC, Kaim SC, et al. Methadyl acetate and methadone as maintenance treatments for heroin addicts. A Veterans Administration cooperative study. Arch Gen Psychiatry 1976;33:709-720.
24. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: A metaanalysis. Addiction 1998;93:515-532.
25. McLellan AT. Patient characteristics associated with outcome. In Cooper JR, Altman F, Brown BS, et al., eds. Research on the Treatment of Drug Addiction: State of the Art (NIDA Research Monograph Series Publication No. ADM 83-1281). Washington, DC: US Government Printing Office; 1983.
26. McLellan AT, Luborsky L, Woody GE, et al. Predicting response to drug and alcohol treatment: Role of psychiatric severity. Arch Gen Psychiatry 1983;40:620-625.
27. Passariello N, Giugliano D, Quatraro A, et al. Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulindependent diabetes. Metabolism 1983;32:1163-1165.
28. Petit JM, Bour JB, Galland-Jos C, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001;35:279-283.
29. Reed JL, Ghodse AH. Oral glucose tolerance and hormonal response in heroin-dependent males. Br Med J 1973;2:582-585.
30. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-848.
31. Smyth B, Hoffman V, Fan J, et al. Years of potential life lost among heroin addicts 33 years after treatment. Prev Med 2007;44:369-374.
32. Strain EC, Stitzer ML, Liebson IA, et al. Dose-response effects ofmethadone in the treatment of opioid dependence. Ann Intern Med 1993;119:23-27.
33. Tan A, Yeh SH, Liu CJ, et al. Viral hepatocarcinogenesis: From infection to cancer. Liver Int 2008;28:175-188.
34. Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race. A case-control study. Am J Gastroenterol 2003;98:438-441.